Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jindan Sheng"'
Autor:
Meixuan Wu, Sijia Gu, Jiani Yang, Yaqian Zhao, Jindan Sheng, Shanshan Cheng, Shilin Xu, Yongsong Wu, Mingjun Ma, Xiaomei Luo, Hao Zhang, Yu Wang, Aimin Zhao
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Purpose Significant advancements in improving ovarian cancer (OC) outcomes have been limited over the past decade. To predict prognosis and improve outcomes of OC, we plan to develop and validate a robust prognosis signature based on blood f
Externí odkaz:
https://doaj.org/article/4bafa82eefd341c6b0f941fea6e970c8
Autor:
Jiani Yang, Chao Wang, Yue Zhang, Shanshan Cheng, Meixuan Wu, Sijia Gu, Shilin Xu, Yongsong Wu, Jindan Sheng, Dominic Chih-Cheng Voon, Yu Wang
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-20 (2023)
Abstract Ovarian cancer (OV) is the most lethal gynecological malignancies worldwide. The coagulation cascade could induce tumor cell infiltration and contribute to OV progression. However, coagulation-related gene (CRG) signature for OV prognosis ha
Externí odkaz:
https://doaj.org/article/795b2ec75dc449909203ae8024b3e111
Autor:
Xiaomei Luo, Yingjie Wang, Hao Zhang, Guangquan Chen, Jindan Sheng, Xiu Tian, Renhao Xue, Yu Wang
Publikováno v:
Biomolecules, Vol 13, Iss 12, p 1724 (2023)
Background: Ovarian cancer (OV) is associated with high mortality and poses challenges in diagnosis and prognosis prediction. Ubiquitin-related genes (UbRGs) are involved in the initiation and progression of cancers, but have still not been utilized
Externí odkaz:
https://doaj.org/article/c0246934222f45129cdd9f4538629909
Autor:
Fumio Matsuda, Paing Linn, Seiji Yano, Sharad Kumar, Hiroshi Inoue, Chiaki Takahashi, Susumu Kohno, Nobuhiro Okada, Naoko Nagatani, Jindan Sheng, Kenichi Harada, Kana Teranishi, Nobuyuki Okahashi, Minako Yamamura, Shunsuke Kitajima, Hiroshi Shimizu, Shin-ichi Horike, Itsuki Ajioka
Publikováno v:
Hepatology. 74:1971-1993
Background and Aims: Synthetic cyclin-dependent kinase (CDK) 4/6 inhibitors exert antitumor effects by forcing RB1 in unphosphorylated status, causing not only cell cycle arrest but also cellular senescence, apoptosis, and increased immunogenicity. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e85334eee1bb1578800e33ee41f098fa
https://doi.org/10.1002/hep.31872
https://doi.org/10.1002/hep.31872
Autor:
Hai Yu, Paing Linn, Nilakshi Kulathunga, Zhiheng Zhang, Chiaki Takahashi, Jindan Sheng, Susumu Kohno, Dominic Chih-Cheng Voon, Yoshihiro Watanabe
Publikováno v:
Cancers, Vol 13, Iss 3737, p 3737 (2021)
Cancers
Cancers
Simple Summary Irreversible defects in RB1 tumor suppressor functions often predict poor outcomes in cancer patients. However, the RB1-defecient status can be a benefit as well for them, as it generates a variety of vulnerabilities induced through th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72cfca71b86391f45223ef5d733fb78d
https://www.mdpi.com/2072-6694/13/15/3737
https://www.mdpi.com/2072-6694/13/15/3737